A carregar...

An Update of Vaccine Therapy and Other Immunotherapeutic Approaches for Glioblastoma

Outcome for glioblastoma (GBM), the most common primary CNS malignancy, remains poor. Overall survival benefit recently achieved with immunotherapeutics for melanoma and prostate cancer support evaluation of immunotherapies for other challenging cancers including GBM. Much historical dogma depicting...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Reardon, David A., Wucherpfennig, Kai W., Freeman, Gordon, Wu, Catherine, Chiocca, E. Antonio, Wen, Patrick Y., Curry, William T., Mitchell, Duane A., Fecci, Peter, Sampson, John H., Dranoff, Glenn
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3982399/
https://ncbi.nlm.nih.gov/pubmed/23750791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/erv.13.41
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!